Osteoimmunomodulatory Gelma/ Liposome Coatings to Promote Bone Regeneration of Orthopedic Implants

Fatemeh Jahanmard,Azin Khodaei,Jip Flapper,Ozan Dogan,Khatereh Roohi,Peyman Taheri,Harrie Weinans,Gert Storm,Michiel Croes,E. Mastrobattista,Saber Amin Yavari
DOI: https://doi.org/10.2139/ssrn.4254099
2022-01-01
SSRN Electronic Journal
Abstract:Immunomodulatory mediators are potentially involved in initiating bone fracture healing. Yet, the lack of a low-cost, efficient, simple, and local therapeutic option to stimulate bone regeneration of large bone defects remains a significant challenge. Liposomes (Lip) are widely used as drug carriers to stimulate immune cells via systemic routes. Local delivery of Lip is, however, needed to increase its therapeutic effect in bone regeneration. Here, we have developed a novel versatile coating strategy for local delivery of Lip with the potential to protect and preserve the integrity as well as immune activity of the Lip. The two differently charged Lip (i.e., anionic and cationic) were blended with gelatin methacryloyl (GelMA) and coated via electrospray technology on the bone-implant surfaces. The results showed that the developed coating withstood mechanical stress during surgical replacement, and Lip inside GelMA coating stayed intact in different storage conditions for a minimum of 4 weeks. Surprisingly, bare Lip, either cationic or anionic, improved the osteogenesis of human Mesenchymal Stem Cells (MSCs) by inducing pro-inflammatory cytokines, even at a low dosage of Lip released from the GelMA coating. More importantly, we showed that the inflammatory response could be fine-tuned by selecting the Lip concentration, Lip/hydrogel ratio, and coating thickness to determine the timing of the release such that we can accommodate different clinical needs. These promising results pave the way to use these Lip coatings to load different types of therapeutic cargo for bone-implant applications.
What problem does this paper attempt to address?